Neil O. Carragher

11.9k total citations · 2 hit papers
130 papers, 7.2k citations indexed

About

Neil O. Carragher is a scholar working on Molecular Biology, Oncology and Biophysics. According to data from OpenAlex, Neil O. Carragher has authored 130 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 29 papers in Oncology and 29 papers in Biophysics. Recurrent topics in Neil O. Carragher's work include Cell Image Analysis Techniques (26 papers), Cell Adhesion Molecules Research (18 papers) and Cellular Mechanics and Interactions (14 papers). Neil O. Carragher is often cited by papers focused on Cell Image Analysis Techniques (26 papers), Cell Adhesion Molecules Research (18 papers) and Cellular Mechanics and Interactions (14 papers). Neil O. Carragher collaborates with scholars based in United Kingdom, United States and Germany. Neil O. Carragher's co-authors include Margaret C. Frame, Valerie G. Brunton, Valerie J. Fincham, Gordon W. McLean, Egle Avizienyte, JEFF EVANS, Elaine W. Raines, Asier Unciti‐Broceta, John C. Dawson and Mike‐Andrew Westhoff and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Neil O. Carragher

123 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of focal-adhesion kinase in cancer — a new therapeutic opportunity

2005 855 citations Neil O. Carragher, Valerie G. Brunton et al. profile →
Screening out irrelevant cell-based models of disease

2016 374 citations Daniel Ebner, Neil O. Carragher et al. profile →

Peers

Countries citing papers authored by Neil O. Carragher

Since Specialization

Citations

This map shows the geographic impact of Neil O. Carragher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil O. Carragher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil O. Carragher more than expected).

Fields of papers citing papers by Neil O. Carragher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil O. Carragher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil O. Carragher. The network helps show where Neil O. Carragher may publish in the future.

Co-authorship network of co-authors of Neil O. Carragher

This figure shows the co-authorship network connecting the top 25 collaborators of Neil O. Carragher. A scholar is included among the top collaborators of Neil O. Carragher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil O. Carragher. Neil O. Carragher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation 2025 ·Disease Models & Mechanisms ·(unknown), John C. Dawson, Virginia Álvarez-García, Morwenna Muir, Roderick N. Carter, Giles E. Hardingham, C J Davies, Robert M. Graham, Alex von Kriegsheim, Jair Mendes Marques, (unknown), Steven M. Pollard, Neil O. Carragher, Valerie G. Brunton, Margaret C. Frame	0
2	High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma 2024 ·Gynecologic Oncology ·Robert L. Hollis, Richard Elliott, John C. Dawson, (unknown), (unknown), (unknown), (unknown), (unknown), Marta Llauradó Fernández, Michael Churchman, (unknown), Patricia Roxburgh, Asier Unciti‐Broceta, David M. Gershenson, C. Simon Herrington, Mark Carey, Neil O. Carragher, Charlie Gourley	5
3	Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767 2024 ·Hepatology Communications ·Prakash Ramachandran, Madara Brice, (unknown), Anna M. Hoy, (unknown), Jia Li, Frances Turner, Timothy J. Kendall, John A. Marwick, Neil O. Carragher, Denise Oró, Michael Feigh, Diana Julie Leeming, Mette Juul Nielsen, M.A. Karsdal, N Hartmann, Mary Erickson, Luciano Adorini, Jonathan D. Roth, Jonathan Fallowfield	1
4	Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia 2023 ·Frontiers in Oncology ·(unknown), (unknown), Sara Erridge, Geoff S. Higgins, Joelle P. Straehla, Margaret C. Frame, Tero Aittokallio, Neil O. Carragher, Daniel Ebner	8
5	Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells 2023 ·RSC Medicinal Chemistry ·(unknown), Teresa Valero, Álvaro Lorente‐Macías, David Jonathan Bennett, Richard Elliott, Neil O. Carragher, Asier Unciti‐Broceta	2
6	Discovery of senolytics using machine learning 2023 ·Nature Communications ·(unknown), Andrea Quintanilla, Richard Elliott, John C. Dawson, (unknown), Víctor M. Campa, Álvaro Lorente‐Macías, Asier Unciti‐Broceta, Neil O. Carragher, Juan Carlos Acosta, Diego A. Oyarzún	67
7	NODAL/TGFβ signalling mediates the self-sustained stemness induced by PIK3CAH1047R homozygosity in pluripotent stem cells 2021 ·Disease Models & Mechanisms ·Ralitsa R. Madsen, James Longden, Rachel Knox, Xavier Robin, (unknown), Kenneth G. MacLeod, Larissa S. Moniz, Neil O. Carragher, Rune Linding, Bart Vanhaesebroeck, Robert K. Semple	5
8	Trichoplein binds PCM 1 and controls endothelial cell function by regulating autophagy 2020 ·EMBO Reports ·Andrea Martello, Angela Lauriola, David Mellis, (unknown), John C. Dawson, Lisa Imrie, (unknown), Noor Gammoh, Tijana Mitić, Mairi Brittan, Nicholas L. Mills, Neil O. Carragher, Domenico D’Arca, Andrea Caporali	24
9	Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF 2019 ·Cancer Immunology Research ·Takanori Kitamura, Yu Kato, Demi Brownlie, Daniel Soong, Gaël Sugano, (unknown), Jiufeng Li, (unknown), Neil O. Carragher, Jeffrey W. Pollard	14
10	A Synergistic Anticancer FAK and HDAC Inhibitor Combination Discovered by a Novel Chemical–Genetic High-Content Phenotypic Screen 2019 ·Molecular Cancer Therapeutics ·John C. Dawson, Bryan Serrels, Adam Byron, Morwenna Muir, (unknown), Amaya García-Muñoz, Alex von Kriegsheim, Daniel Lietha, Neil O. Carragher, Margaret C. Frame	19
11	N-cadherin stabilises neural identity by dampening anti-neural signals 2019 ·Development ·(unknown), (unknown), (unknown), Guillaume Blin, K G Macleod, Neil O. Carragher, Tim Pieters, Frans van Roy, (unknown), Sally Lowell	18
12	Machine Learning Enables Live Label-Free Phenotypic Screening in Three Dimensions 2018 ·Assay and Drug Development Technologies ·Eoghan O’Duibhir, J Paris, Hannah Lawson, Catarina Sepúlveda, (unknown), Neil O. Carragher, Kamil R. Kranc	8
13	Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action 2017 ·Metallomics ·Jessica M. Hearn, G. M. Hughes, Isolda Romero‐Canelón, Alison F. Munro, Belén Rubio‐Ruíz, Zhe Liu, Neil O. Carragher, Peter J. Sadler	41
14	Development of the Theta Comparative Cell Scoring Method to Quantify Diverse Phenotypic Responses Between Distinct Cell Types 2016 ·Assay and Drug Development Technologies ·Scott Warchal, John C. Dawson, Neil O. Carragher	14
15	Inhibition of NF-κB Signaling Ablates the Invasive Phenotype of Glioblastoma 2013 ·Molecular Cancer Research ·Mike‐Andrew Westhoff, Shaoxia Zhou, Lisa Nonnenmacher, Georg Karpel‐Massler, (unknown), Matthias Schneider, Marc‐Eric Halatsch, Neil O. Carragher, Bernd Baumann, (unknown), Thomas Simmet, Max G. Bachem, Christian Rainer Wirtz, Klaus‐Michael Debatin	58
16	Intravital FLIM-FRET Imaging Reveals Dasatinib-Induced Spatial Control of Src in Pancreatic Cancer 2013 ·Cancer Research ·Max Nobis, Ewan J. McGhee, Jennifer P. Morton, Juliane P. Schwarz, Saadia A. Karim, Jean A. Quinn, Mike Edward, Andrew D. Campbell, Lynn McGarry, T.R. Jeffry Evans, Valerie G. Brunton, Margaret C. Frame, Neil O. Carragher, Yingxiao Wang, Owen J. Sansom, Paul Timpson, Kurt I. Anderson	99
17	Spatial Regulation of RhoA Activity during Pancreatic Cancer Cell Invasion Driven by Mutant p53 2011 ·Cancer Research ·Paul Timpson, Ewan J. McGhee, Jennifer P. Morton, Alex von Kriegsheim, Juliane P. Schwarz, Saadia A. Karim, Brendan Doyle, Jean A. Quinn, Neil O. Carragher, Mike Edward, Michael F. Olson, Margaret C. Frame, Valerie G. Brunton, Owen J. Sansom, Kurt I. Anderson	109
18	High-Content Phenotypic Profiling of Drug Response Signatures across Distinct Cancer Cells 2010 ·Molecular Cancer Therapeutics ·Peter D. Caie, (unknown), (unknown), Sandeep Daya, Thomas M. Houslay, (unknown), Mark Roberts, Neil O. Carragher	113
19	Real-time Study of E-Cadherin and Membrane Dynamics in Living Animals: Implications for Disease Modeling and Drug Development 2009 ·Cancer Research ·Alan Serrels, Paul Timpson, Marta Canel, Juliane P. Schwarz, Neil O. Carragher, Margaret C. Frame, Valerie G. Brunton, Kurt I. Anderson	58
20	The impact of ZD4054, a specific endothelin A receptor antagonist, on tumor blood supply, invasion, and the bone microenvironment 2007 ·Molecular Cancer Therapeutics ·Jon Curwen, Gareth Hughes, (unknown), Nigel Curtis, J Growcott, Beverley Isherwood, Neil O. Carragher	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact